O72.102
Other immediate postpartum hemorrhage; delivered with mention of postpartum complication
O72.202
Delayed and secondary postpartum hemorrhage; delivered with mention of postpartum complication.
O90.202
Hematoma of obstetric wound, delivered with mention of postpartum complication. 
Additional codes Inclusions

5.MD.53.^^Forceps traction and rotation delivery
OVERVIEW
Primary Postpartum Hemorrhage (PPH) is defined as excessive bleeding that occurs within the first 24 hours after delivery. Traditionally the definition of PPH has been blood loss in excess of 500 mL after vaginal delivery and in excess of 1000 mL after abdominal delivery. For clinical purposes, any blood loss that has the potential to produce hemodynamic instability should be considered PPH. The amount of blood loss required to cause hemodynamic instability will depend on the pre-existing condition of the woman. Hemodynamic compromise is more likely to occur when conditions such as anemia (e.g., iron deficiency, thalassemia) or volume-contracted states (e.g., dehydration, gestational hypertension with proteinuria) ) are present. Blood loss is difficult to estimate, and is frequently underestimated . Healthy women can compensate for significant blood loss before exhibiting marked signs and symptoms. This underscores the importance of clinical vigilance to manage patients who experience PPH and to ensure the development and implementation of protocols and practices to actively manage the third stage of labour (the period following the completed delivery of the newborn until the completed delivery of the placenta) to prevent PPH (WHO, 2012; . PPH is one of the few obstetric complications with an effective preventive intervention and it is generally assumed that by preventing and treating PPH, most PPH-associated deaths could be avoided (Mathai et al, 2007; WHO, 2012) .
There are several possible reasons for severe bleeding during and after the third stage of labour, often referred to as the four T's:
• Tone or uterine atony: abnormalities of uterine contraction;
• Tissue: retained placenta, products of conception;
• Trauma of the genital tract: lacerations of the cervix, vagina or perineum; uterine rupture; uterine inversion; and
• Thrombin: abnormalities of coagulation due to pre-existing states such as haemophilia A and von Willebrand's Disease, or acquired in pregnancy such as Immune Thrombocytopenic Purpura (ITP) or Disseminated Intravascular Coagulation (DIC) ).
Tone or "uterine atony" is the leading cause of immediate PPH (75 to 90 per cent) (Koh et al., 2009 ).
Secondary PPH is defined as excessive vaginal bleeding from 24 hours after delivery, to up to six weeks postpartum. Most cases of delayed PPH are due to retained products of conception, choriocarcinoma, infection, and subinvolution of the placental implantation site. Other causes include, lower genital tract lacerations/hematoma, surgical injury, dehiscence of Caesarean section scar, fibroids and arteriovenous malformation and coagulopathies (Alexander, Thoas, Sanghera, 2002; ACOG, 2006; Aiken, Mehasseb, Prentice, 2012) .
Instrumentation and C-Section: Some obstetrical interventions are found to consistently be associated with higher rates of blood loss at the time of delivery thus predisposing patients to developing PPH. Included interventions are instrumental deliveries, episiotomy and Caesarean sections, with emergency Caesarean sections associated with higher rates of blood loss. It is important to note that more recent studies suggest that some obstetrical interventions increase the likelihood of PPH in a subsequent pregnancy, and that the recent increase in PPH in developed countries, which cannot seem to be wholly explained by factors related to the current pregnancy and delivery, may be due to more distal contributory factors (Roberts et al., 2009; Briley et al., 2014) . , offers guidance on assessing for risk factors on admission as well as during labour and postpartum (see details of risk factors listed below). Additional risk factors that may develop in labour include:
Risk Factors for PPH
• Prolonged second stage.
• Prolonged oxytocin use.
• Active bleeding.
• Chorioamnionitis.
• Magnesium Sulfate treatment.
Additional third stage/postpartum risk factors for hemorrhage stemming from the birth process include:
• Vacuum-or forceps-assisted birth.
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• Caesarean birth (especially urgent/emergent Caesarean).
• Retained placenta.
IMPLICATIONS
Postpartum hemorrhage is the leading cause of maternal death worldwide, with an estimated mortality rate of 140 000 per year, or one maternal death every four minutes. PPH occurs in five per cent of all deliveries and is responsible for a major part of maternal mortality. The majority of these deaths occur within four hours of delivery, which indicates that they are a consequence of the third stage of labour. Nonfatal PPH results in further interventions, such as uterine exploration, evacuation or surgical procedures. Other implications include: iron deficiency anemia, exposure to blood products, coagulopathy, and organ damage with associated hypotension and shock which has the potential to jeopardize future fertility ).
Despite the use of uterotonics and active management of third stage of labour to prevent PPH, increases in PPH rates have been reported from high income countries, including Canada, the United States, the United Kingdom and Australia. Rates of severe PPH and of transfusion for treatment also appear to be rising. 
GOAL
To prevent obstetrical hemorrhage from the pelvic area, genital tract, or perineum following vaginal delivery and from surgical incision after an instrument-assisted delivery or Caesarean section.
IMPORTANCE FOR PATIENTS AND FAMILIES
By following the recommended strategies for active management of the third stage of labour, a hospital team can reduce the chance of harm for both mother and baby.
Patient Story
Melissa Price, the patient representative on the hemorrhage task force, had a late postpartum hemorrhage. Melissa ended up with a hysterectomy and about 12 units of blood transfused. While in the Emergency Department, Melissa recalls asking the nurses how they could tell how much blood she was losing -the nurses never weighed the blood, and dumped it from a bed pan into a portable toilet. After Melissa's obstetrician got the bleeding to stop, she was left alone behind a curtain and checked on infrequently. Melissa recalls the feeling sheer panic when the bleeding started up again with 'enormous clots'… "I screamed and I will never forget the look on the nurse's face when she lifted up that blanket. After that, ER staff was running around everywhere. Rushing to call my OB, rushing to get an OR suite, rushing to figure out how to get my insulin pump turned off. I just kept thinking, God give them more time. They need more time to save me." .
EVIDENCE INFORMED PRACTICE
Prevention of Primary Postpartum Hemorrhage 1. System Readiness 1. Construct a sterile tray that provides rapid access to instruments used to surgically treat PPH .
2. Construct a sterile tray that provides rapid access to a hysterectomy tray .
3. Conduct regularly scheduled simulation drills for practicing response to obstetric hemorrhage .
4. Adopt and maintain an obstetrical hemorrhage emergency management plan which includes the activation of maternal hemorrhage response team as clinically needed .
Time of Admission 1. Identify and manage patients with special consideration:
• Placenta previa/accrete.
• Bleeding disorder.
• Anemia.
• Those who decline blood products (ACOG, 2012; .
• Anticoagulant use (Nakajima, 2016).
2. Assess hemorrhage risk on admission, throughout labour, postpartum and at every handoff (ACOG, 2012; :
• If medium risk: Type and Screen and review hemorrhage protocol.
• If high risk: Type and crossmatch 2 units of PRBCs, review hemorrhage protocol and notify OB provider and/or anesthesia . [Note #4 and #7 for specific recommendations related to Caesarean section]
Third Stage of Labour
1. Active management of the third stage of labour (AMTSL) reduces the risk of PPH and should be offered and recommended to all women. AMTSL involves interventions to assist in expulsion of the placenta with the intention to prevent or decrease blood loss.
Interventions include use of uterotonics, clamping of the umbilical cord, and controlled traction of the cord.
2. Oxytocin (10 IU), administered intramuscularly, is the preferred medication and route for the prevention of PPH in low-risk vaginal deliveries. Care providers should administer this medication after delivery of the anterior shoulder.
3. Intravenous infusion of oxytocin (20 to 40 IU in 1000 mL, 150 mL per hour) is an acceptable alternative for AMTSL.
4. An IV bolus of oxytocin, 5 to 10 IU (given over one to two minutes), may be used for PPH prevention after vaginal birth, but is not recommended at this time with elective Caesarean section.
5. Ergonovine can be used for prevention of PPH, but may be considered second choice to oxytocin due to the greater risk of maternal adverse effects and the need for manual removal of a retained placenta. Ergonovine is contraindicated in patients with hypertension.
6. Ergonovine, 0.2 mg IM, and misoprostol, 600 to 800 g given by the oral, sublingual, or rectal route, may be offered as alternatives in vaginal deliveries when oxytocin is not available.
7. Carbetocin, 100 g given as an IV bolus over one minute, may be used instead of continuous oxytocin infusion in elective Caesarean section for the prevention of PPH and to decrease the need for therapeutic uterotonics.
8. For women delivering vaginally with one risk factor for PPH, carbetocin 100 g IM decreases the need for uterine massage to prevent PPH when compared with continuous infusion of oxytocin.
9. Whenever possible, delaying cord clamping by at least 60 seconds is preferred to clamping earlier in premature newborns (< 37 weeks gestation) since there is less intraventricular hemorrhage and less need for transfusion in those with late clamping.
10. For term newborns, the possible increased risk of neonatal jaundice requiring phototherapy must be weighed against the physiological benefit of greater hemoglobin and iron levels up to six months of age conferred by delayed cord clamping.
11. There is no evidence that in an uncomplicated delivery without bleeding, interventions to accelerate delivery of the placenta before the traditional 30 to 45 minutes will reduce the risk of PPH.
12. Placental cord drainage cannot be recommended as a routine practice since the evidence for a reduction in the duration of the third stage of labour is limited to women who did not receive oxytocin as part of the management of the third stage. There is no evidence that this intervention prevents PPH.
[Note: refer to .
3. Continue to monitor the patient for signs and symptoms of secondary PPH.
4. Development and implementation of protocols for the management of the third stage of labour include the use of uterotonic agents to prevent PPH. Protocols for management of ongoing PPH will also address the other possible etiologies of PPH in addition to uterine atony, including retained placenta, genital tract trauma, and defects in coagulation. Adherence to protocols for third stage management and for PPH will improve patient outcomes.
Conduct Clinical and System Reviews (see details below)
Given the broad range of potential causes of hemorrhage, in addition to recommendations listed above, we recommend conducting clinical and system reviews to identify latent causes and determine appropriate recommendations.
Clinical and System Reviews, Incident Analyses
Occurrences of harm are often complex with many contributing factors. Organizations need to:
1. Measure and monitor the types and frequency of these occurrences.
2. Use appropriate analytical methods to understand the contributing factors.
3. Identify and implement solutions or interventions that are designed to prevent recurrence and reduce risk of harm.
4. Have mechanisms in place to mitigate consequences of harm when it occurs.
To develop a more in-depth understanding of the care delivered to patients, chart audits, incident analyses and prospective analyses can be helpful in identifying quality improvement opportunities. Links to key resources for analysis methods are included in Resources for Conducting Incident and/or Prospective Analyses section of the Introduction to the Hospital Harm Improvement Resource.
Chart audits are recommended as a means to develop a more in-depth understanding of the care delivered to patients identified by the Hospital Harm measure. Chart audits help identify quality improvement opportunities.
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Useful resources for conducting clinical and system reviews:
• Chart Audit Review Process (see Introduction to the Improvement Resource)
• Canadian Incident Analysis Framework 
MEASURES
Vital to quality improvement is measurement, and this applies specifically to implementation of interventions. The chosen measures will help to determine whether an impact is being made (primary outcome), whether the intervention is actually being carried out (process measures), and whether any unintended consequences ensue (balancing measures).
Below are some recommended measures to use, as appropriate, to track your progress. In selecting your measures, consider the following:
• Whenever possible, use measures you are already collecting for other programs.
• Evaluate your choice of measures in terms of the usefulness of the final results and the resources required to obtain them; try to maximize the former while minimizing the latter.
• Try to include both process and outcome measures in your measurement scheme.
• You may use different measures or modify the measures described below to make them more appropriate and/or useful to your particular setting. However, be aware that modifying measures may limit the comparability of your results to others.
• Posting your measure results within your hospital is a great way to keep your teams motivated and aware of progress. Try to include measures that your team will find meaningful and exciting (IHI, 2012) . 6. Per cent of patients with vaginal delivery (with and/or without instrumentation) delivering a premature newborn (<37 weeks) for whom cord clamping was performed up to 60 seconds after delivery.
7. Percentage of patients with vaginal delivery (with and/or without instrumentation) who had prompt and careful examination of the birth canal and repair of lacerations.
8. Percentage of patients assessed at least once per shift for risk of hemorrhage during the postpartum period.
9. Percentage of patients who had ongoing monitoring for signs and symptoms of secondary PPH.
STANDARDS AND REQUIRED ORGANIZATIONAL PRACTICES
Accreditation Canada does not have any Standards or Required Organizational Practices that are directly related to obstetric hemorrhage.
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GLOBAL PATIENT SAFETY ALERTS
Global Patient Safety Alerts (GPSA) provides access and the opportunity to learn from other organizations about specific patient safety incidents including alerts, advisories, recommendations and solutions for improving care and preventing incidents.
Recommended search terms:
• After approval for a new hospital procedure, the team concept was discussed and refined through the Hospital Committees of all the team members and those they would interact with, and then put into operation within a week. Review of six months of data after "Ob Stat Team" introduction revealed the time from team activation to delivery had a mean of 10.9+/-4.0 minutes, with a range of four to 19 minutes. In a team activation for uterine rupture during a VBAC, delivery was within six minutes and 30 seconds from onset of bradycardia. A different approach to problem solving by a small team, followed by continual monitoring and adaptation of the "Ob Stat Team" dramatically improved response times to obstetric emergencies compared with other institutions (Catanzarite, Almryde, Bombard, 2007 
OBSTETRICAL HEMORRHAGE RESOURCES Professional Associations and Helpful Websites
• American Congress of Obstetricians and Gynecologists
• Royal College of Obstetricians and Gynaecologists
• The California Maternal Quality Care Collaborative (CMQCC)
• The Society of Obstetricians and Gynaecologists of Canada (SOGC)
• The WHO Reproductive Health Library 
Clinical Practice Guidelines
